Physician profile
Isador H Lieberman
NPI 1033173901
$1,284,367.73
in general payments reported to CMS, 2019-2025
32 companies · $442K in 2025
The $442K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $44K · 2021: $71K · 2022: $80K · 2023: $219K · 2024: $357K · 2025: $442K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $789K · Consulting Fee: $157K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Travel and Lodging: $6,621 · Food and Beverage: $5,737 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $788,644.20 |
| Consulting Fee | $157,179.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,000.00 |
| Travel and Lodging | $6,620.89 |
| Food and Beverage | $5,736.65 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $997,662.24 | 2019-2025 | |
| Bioventus LLC | $83,060.36 | 2022-2025 | Bonescalpel & Sonicone (O.R.), Bonescalpel, None |
| Medtronic USA, INC. | $46,328.98 | 2019-2020 | |
| Misonix INC | $38,500.00 | 2019-2021 | |
| Medical Device Business Services, INC. | $35,554.70 | 2020-2025 | Conduit, Velys, Spine & Trauma 3d Navigation |
| Medtronic, INC. | $27,916.22 | 2021-2022 | |
| Ecential Robotics | $26,987.40 | 2023-2024 | |
| Carbofix Spine INC | $7,605.46 | 2024-2025 | Carboclear Pedical Screw System |
| Depuy Synthes Products, INC. | $7,339.69 | 2023-2025 | Velys |
| Globus Medical, INC. | $3,442.40 | 2019-2025 | Creo Threaded, Creo, Creo Mcs, Fenestrated, Sideloading |
| Synthes Gmbh | $3,067.22 | 2021-2024 | |
| Camber Spine Technologies LLC | $1,586.02 | 2021-2022 | |
| Stryker Corporation | $1,013.63 | 2019-2025 | |
| Musculoskeletal Transplant Foundation INC. | $690.00 | 2024 | |
| Depuy Synthes Sales INC. | $605.06 | 2023-2025 | Velys, Mtf, Teligen |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $490.33 | 2023-2025 | Magnetos |
| Spineology INC. | $320.29 | 2019 | |
| Orthofix Medical, INC. | $267.90 | 2019-2025 | Mariner Deformity |
| Degen Medical, INC. | $260.96 | 2024 | |
| Nuvasive, INC. | $250.36 | 2019-2022 | |
| Painteq LLC | $226.24 | 2023 | Painteq |
| Pacira Pharmaceuticals Incorporated | $203.94 | 2023 | Exparel, Iovera, Zilretta |
| Augmedics INC. | $190.35 | 2022 | |
| Acuity Surgical Devices, LLC | $142.11 | 2020 | |
| Wenzel Spine, INC. | $141.51 | 2022 | |
| Zimmer Biomet Holdings, INC. | $122.85 | 2021 | |
| Alphatec Spine, INC | $89.55 | 2022 | |
| Highridge Medical LLC | $88.23 | 2024 | Spine-None |
| Vertebral Technologies, INC. | $80.98 | 2019 | |
| Nanovis LLC | $80.00 | 2021 | |
| Curiteva, INC. | $52.75 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isador Lieberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.